British vets could face price caps and ban on bonuses linked to pet treatments – business live


UK vets could face price cap on medicines and ban on incentives linked to treatments

Two puppies at a UK vet in 2023. Photograph: Brian Lawless/PA

British vets could face price caps on medicines and prescription fees and a ban on bonuses linked to certain treatments, as the regulator looks into concerns that pet owners are being ripped off.

The Competition and Markets Authority (CMA) is looking into the veterinary industry, after a flood of 56,000 people raised concerns about the £2bn sector. The CMA said it has concerns that competition is not functioning properly in the market, which is increasingly dominated by a handful of firms.

In a working paper published on Thursday, the CMA set out possible remedies including breaking the link between treatment choice and bonuses for vets.

The CMA said it was looking at:

banning any practices, including the structuring of practice management systems or use of targets or financial incentives, which limit vets’ clinical freedom to provide a choice of treatments suited to the pet owner and animal’s requirements. […]

abolishing or imposing price caps on prescription and dispensing fees […]

the possible benefits and risks of implementing a short-term, temporary ‘stabilising’ freeze or cap on medicine prices while the competition benefits of the broader package of measures come into effect.

Vets could also be forced to display clearly online a set of prices for medicines, surgeries, treatments and out-of-hours help, while the mark-up they can charge on cremations – sold to customers “at a vulnerable moment” – could also be capped.

Share

Updated at 

Key events

Mark Tucker, group chair of HSBC, speaking at a conference in Shanghai, China, in 2018. Photograph: Xinhua/Alamy

HSBC chair Mark Tucker will retire before the end of the year, the UK-headquartered bank said on Thursday.

Tucker has been chair since 2017, including through the turmoil of the coronavirus pandemic, and oversaw the appointment of Georges Elhedery as chief executive last year.

The new chair will have to navigate the increasing strain between the UK, its headquarters, and China, the centre of its profits and the place where it is expected to grow. HSBC has often found itself in tricky situations particularly when China’s authoritarian government clamped down on human rights in Hong Kong.

Ann Godbehere, HSBC’s senior independent non-executive director, will lead a search for his successor, HSBC said.

Tucker said:

It has been a great honour and privilege to lead HSBC as chair. I am deeply grateful for the trust and support I have received from the Board, management, and colleagues and am very proud of all that we have accomplished together.

With the strong foundations laid over the last eight plus years, I am very confident that under Georges’ leadership, HSBC will go from strength to strength.



Source link

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles